BRCA1 and BRCA2 genes: Role in hereditary breast and ovarian cancer in Italy

International Journal of Cancer

Volumn 83, Issue 1, 1999, Pages 5-9

  Santarosa, Manuela ^a   Dolcetti, Riccardo ^a   Magri, Maria Donatella ^a   Crivellari, Diana ^a   Tibiletti, Maria Grazia ^b   Gallo, Angelo ^a   Tumolo, Salvatore ^c   Puppa, Lara Della ^a   Furlan, Daniela ^b   Boiocchi, Mauro ^a   Viel, Alessandra ^a  

^a CENTRO DI RIFERIMENTO ONCOLOGICO   (Italy)

^b UNIVERSITY OF INSUBRIA   (Italy)

^c Pordenone Hospital   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; BREAST CARCINOGENESIS; BREAST CARCINOMA; CANCER INCIDENCE; CANCER SUSCEPTIBILITY; CONTROLLED STUDY; DNA SEQUENCE; FAMILY HISTORY; FRAMESHIFT MUTATION; HUMAN; MAJOR CLINICAL STUDY; ONCOGENE; OVARY CARCINOMA; PRIORITY JOURNAL; PROTEIN EXPRESSION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; RNA ANALYSIS;

ADULT; AGE OF ONSET; AGED; BRCA2 PROTEIN; BREAST NEOPLASMS; BREAST NEOPLASMS, MALE; FEMALE; GENES, BRCA1; GENETIC PREDISPOSITION TO DISEASE; GERM-LINE MUTATION; HUMANS; ITALY; MALE; MIDDLE AGED; NEOPLASM PROTEINS; OVARIAN NEOPLASMS; POLYMORPHISM, SINGLE-STRANDED CONFORMATIONAL; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RISK FACTORS; TRANSCRIPTION FACTORS;

EID: 0032845320     PISSN: 00207136     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1097-0215(19990924)83:1<5::AID-IJC2>3.0.CO;2-U     Document Type: Article

References (17)

1. BURKE, W., DALY, M., GARBER, J., BOTKIN, J., KAHN, M.J., LYNCH, P., MCTIERNAN, A., OFFIT, K., PERLMAN, J., PETERSEN, G., THOMSON, E. and VARRICCHIO, C., Recommendations for follow-up care of individuals with an inherited predisposition to cancer. II. BRCA1 and BRCA2. Cancer Genetics Studies Consortium. J. Amer. med. Ass., 277, 997-1003 (1997).
2. COLLINS, N., MCMANUS, R., WOOSTER, R., MANGION, J., SEAL, S., LAKHANI, S.R., ORMISTON, W., DALY, P.A., FORD, D., EASTON, D.F. and STRATTON, M.R., Consistent loss of the wild type allele in breast cancers from a family linked to the BRCA2 gene on chromosome 13q12-13. Oncogene, 10, 1673-1675 (1995).
3. FOSTER, K.A., HARRINGTON, P., KERR, J., RUSSELL, P., DICIOCCIO, R.A., SCOTT, I.V., JACOBS, I., CHENEVIX-TRENCH, G., PONDER, B.A. and GAYTHER, S.A., Somatic and germline mutations of the BRCA2 gene in sporadic ovarian cancer. Cancer Res., 56, 3622-3625 (1996).
4. HARALDSSON, K., LOMAN, N., ZHANG, Q.X., JOHANNSSON, O., OLSSON, H. and BORG, A., BRCA2 germline mutations are frequent in male breast cancer patients without a family history of the disease. Cancer Res., 58, 1367-1371 (1998).
5. LANCASTER, J.M. and 19 OTHERS, BRCA2 mutations in primary breast and ovarian cancers. Nature Genet., 13, 238-240 (1996).
6. MAZOYER, S. and 12 OTHERS, A polymorphic stop codon in BRCA2. Nature Genet., 14, 253-254 (1996).
7. MCALLISTER, K.A., HAUGEN-STRANO, A., HAGEVIK, S., BROWNLEE, H.A., COLLINS, N.K., FUTREAL, P.A., BENNETT, L.M. and WISEMAN, R.W., Characterization of the rat and mouse homologues of the BRCA2 breast cancer susceptibility gene. Cancer Res., 57, 3121-3125 (1997).
8. MIKI, Y. and 44 OTHERS, A strong candidate for the breast and ovarian cancer susceptibility gene BRCA1. Science, 266, 66-71 (1994).
9. MIKI, Y., KATAGIRI, T., KASUMI, F., YOSHIMOTO, T. and NAKAMURA, Y., Mutation analysis in the BRCA2 gene in primary breast cancers. Nature Genet., 13, 245-247 (1996).
10. ÖZÇELIK, H., SCHMOCKER, B., DI NICOLA, N., SHI, X.H., LANGER, B., MOORE, M., TAYLOR, B.R., NAROD, S.A., DARLINGTON, G., ANDRULIS, I.L., GALLINGER, S. and REDSTON, M., Germline BRCA2 6174delT mutations in Ashkenazi Jewish pancreatic cancer patients. Nature Genet., 16, 17-18 (1997).
11. ROA, B.B., BOYD, A.A., VOLCIK, K. and RICHARDS, C.S., Ashkenazi Jewish population frequencies for common mutations in BRCA1 and BRCA2. Nature Genet., 14, 185-187 (1996).
12. SANTAROSA, M., VIEL, A., DOLCETTI, R., CRIVELLARI, D., MAGRI, M.D., PIZZICHETTA, A., TIBILETTI, M.G., GALLO, A., TUMOLO, S., DEL TIN, L. and BOIOCCHI, M., Low incidence of BRCA1 mutations among Italian families with breast and ovarian cancer. Int. J. Cancer, 78, 581-586 (1998).
13. SCHUBERT, E.L., LEE, M.K., MEFFORD, H.C., ARGONZA, R.H., MORROW, J.E., HULL, J., DANN, J.L. and KING, M.C., BRCA2 in American families with four or more cases of breast or ovarian cancer: recurrent and novel mutations, variable expression, penetrance, and the possibility of families whose cancer is not attributable to BRCA1 or BRCA2. Amer. J. hum. Genet., 60, 1031-1040 (1997).
14. SZABO, C.I. and KING, M.C., Population genetics of BRCA1 and BRCA2. Amer. J. hum. Genet., 60, 1013-1020 (1997).
15. TAVTIGIAN, S.V. and 50 OTHERS, The complete BRCA2 gene and mutations in chromosome 13q-linked kindreds. Nature Genet., 12, 333-337 (1996).
16. THORLACIUS, S., OLAFSDOTTIR, G., TRYGGVADOTTIR, L., NEUHAUSEN, S., JONASSON, J.G., TAVTIGIAN, S.V., TULINIUS, H., ÖGMUNDSDOTTIR, H.M. and EYFJÖRD, J.E., A single BRCA2 mutation in male and female breast cancer families from Iceland with varied cancer phenotypes. Nature Genet., 13, 117-119 (1996).
17. WOOSTER, R. and 40 OTHERS, Identification of the breast cancer susceptibility gene BRCA2. Nature (Lond.), 378, 789-792 (1995).